ITCC-086 Abemaciclib
A Phase 1b, Dose Escalation Study of Abemaciclib in Combination with Temozolomide and Irinotecan (triplet escalation) and Abemaciclib in combination with Temozolomidea
Promotor Name : Eli Lilly
Investigator Name :
Trial registered on clinicaltrial.gov: NCT04238819
